China to Allow Use of Overseas Trial Data in Drug Applications

Clinical Trials Advisor
A A
In a significant policy shift, China plans to accept data from foreign clinical trials in its drug approval process if the drug is already approved overseas.

To View This Article:

Login

Subscribe To Clinical Trials Advisor